SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

UPLOAD Filing

Q32 Bio Inc.
Date: Aug. 28, 2025 · CIK: 0001661998 · Accession: 0000000000-25-009296

Financial Reporting Regulatory Compliance

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 001-38433

Date
August 28, 2025
Author
Finance
Form
UPLOAD
Company
Q32 Bio Inc.

Letter

Re: Q32 Bio Inc. Form 10-K for the year ended December 31, 2024 Filed March 11, 2025 File No. 001-38433 Dear Lee Kalowski:

August 28, 2025

Lee Kalowski CFO and President Q32 Bio Inc. 830 Winter Street Waltham, MA 02451

We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.

Sincerely,
Division of Corporation
Finance
Office of Life Sciences

Show Raw Text
<DOCUMENT>
<TYPE>TEXT-EXTRACT
<SEQUENCE>2
<FILENAME>filename2.txt
<TEXT>
 August 28, 2025

Lee Kalowski
CFO and President
Q32 Bio Inc.
830 Winter Street
Waltham, MA 02451

 Re: Q32 Bio Inc.
 Form 10-K for the year ended December 31, 2024
 Filed March 11, 2025
 File No. 001-38433
Dear Lee Kalowski:

 We have completed our review of your filing. We remind you that the
company and
its management are responsible for the accuracy and adequacy of their
disclosures,
notwithstanding any review, comments, action or absence of action by the staff.

 Sincerely,

 Division of Corporation
Finance
 Office of Life Sciences
</TEXT>
</DOCUMENT>